3C
AMGN icon

361 Capital’s Amgen AMGN Stock Holding History

361 Capital’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$574K Buy
+2,434
New +$555K 0.27% 206
2017
Q1 		– Sell
-34,552
Closed -$5.05M – 162
2016
Q4 		$5.05M Buy
+34,552
New +$5.2M 1.2% 38

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

361 Capital's AMGN Position: Q2 2020 in Review

361 Capital opened a new position in Amgen (AMGN) in Q2 2020: 2,434 shares worth $574K. The stake represents 0.27% of the portfolio and ranks #206 among its holdings. This is a return to the name: 361 Capital previously reported a position in AMGN as recently as Q4 2016.

361 Capital first reported a position in AMGN in Q4 2016 and has held it in 2 quarters since. The position peaked at $5.05M in Q4 2016. 2,091 funds tracked by Wall St. Rank hold AMGN as of Q2 2020.

  • 361 Capital held 2,434 shares of Amgen worth $574K as of Q2 2020.
  • Amgen was a new 361 Capital position in Q2 2020.
  • Amgen made up 0.27% of 361 Capital's portfolio in Q2 2020, its #206 holding.
  • 361 Capital first reported a position in Amgen in Q4 2016 and has held it in 2 quarters since.
  • 361 Capital's Amgen position peaked at $5.05M in Q4 2016.
  • 2,091 funds tracked by Wall St. Rank held Amgen as of Q2 2020.

Based on 361 Capital's 13F filing for Q2 2020, filed 14 Aug 2020.